ASPECTE DE FARMACOCINETICĂ PRIVIND PRODUSUL AUGMENTIN BIS

December 1, 1998

E. Manolescu *
* Prof. Dr. Emanoil Manolescu – Catedra de Farmacologie U.M.F, Carol Davila, Bucureşti

Abstract

The pharmacokinetic aspects of the amoxicil lin – clavulonat association, including a comparison between the Augmentin bis formula (7/1 x b.i.d) and the Augmentin formula (4/1 x t.i.d.) are presented. lt results the advantages of the Augmentin bis formula, especially in pediatric conditions.

Previous article in this issue

TRATAMENTUL CU AMOXICILINĂ – ACID CLAVULANIC – FORMULA BIS

Next article in this issue

KLACID, ANTIBIOTIC DE PRIMĂ INTENŢIE ÎN INFECŢIILE ACUTE RESPIRATORII LA COPIL